June 4, 2026 - 04:31

OSE Immunotherapeutics SA announced its audited consolidated financial results for the full year 2025 on June 3, 2026. The company confirmed that the audited figures are consistent with the unaudited financial statements previously released on April 30, 2026.
A key development noted in the report is the IRIS Financing, announced on May 28, 2026. This transaction has been recorded as a subsequent event in the audited statements. As a result of this financing, OSE Immunotherapeutics now projects a cash runway that extends until the end of December 2026.
The company also confirmed that its Universal Registration Document for the 2025 fiscal year has been filed. The financial results were approved by the Board of Directors and released after market close on June 3, 2026. OSE Immunotherapeutics is based in Nantes, France, and is publicly traded on the Euronext Paris exchange.
June 3, 2026 - 03:30
Government pressed on granny flat rule as budget changes rushed throughThe federal government is facing mounting pressure to provide clear definitions around granny flat arrangements as it pushes major capital gains tax and negative gearing changes through parliament....
June 2, 2026 - 18:41
GitLab Reports First Quarter Fiscal Year 2027 Financial ResultsSAN FRANCISCO, June 02, 2026 -- GitLab Inc., the company behind the all-remote DevSecOps platform, announced its financial results for the first quarter of fiscal year 2027, which ended on April 30...
June 2, 2026 - 13:00
NZX Midday Sector Update: Retail Trade Shares Rise, Finance DeclinesRetail trade stocks posted the strongest performance on the New Zealand Exchange by midday Tuesday, climbing more than 1% as investors rotated into consumer-focused sectors. The gain pushed the...
June 1, 2026 - 18:20
Security Financial Services Inc Opens iShares International Country Rotation ETF Stake Valued at $30 MillionA new regulatory filing reveals that Security Financial Services Inc has acquired a position in the iShares International Country Rotation ETF, with the stake valued at approximately $30 million....